- This version of the UK Core is a development copy.
- This contains BREAKING CHANGES as a result of the C&TA Sprint 7 Review, and STU2 Sequence ballot reconciliation.
- This version is not yet reviewed for implementation. Other versions are available on the UK Core Version History Guide
- Please follow the guidance on the Contact Us page if you need any assistance.
- A summary of changes is available on the STU3 Sequence Change Log
StructureDefinition UKCore-Medication
Canonical_URL | Status | Current_Version | Last_Updated | Description |
---|---|---|---|---|
https://fhir.hl7.org.uk/StructureDefinition/UKCore-Medication | active | 2.3.0 | 2023-12-12 | This profile defines the UK constraints and extensions on the International FHIR resource Medication. |
Profile_Purpose |
---|
This profile is primarily used for the identification and definition of a medication for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use. |
Detailed Descriptions
Medication | |
Definition | This resource is primarily used for the identification and definition of a medication for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use. |
Cardinality | 0...* |
Invariants |
|
Mappings |
|
Medication.id | |
Definition | The logical id of the resource, as used in the URL for the resource. Once assigned, this value never changes. |
Cardinality | 0...1 |
Type | string |
Summary | True |
Comments | The only time that a resource does not have an id is when it is being submitted to the server using a create operation. |
Medication.meta | |
Definition | The metadata about the resource. This is content that is maintained by the infrastructure. Changes to the content might not always be associated with version changes to the resource. |
Cardinality | 0...1 |
Type | Meta |
Summary | True |
Invariants |
|
Mappings |
|
Medication.implicitRules | |
Definition | A reference to a set of rules that were followed when the resource was constructed, and which must be understood when processing the content. Often, this is a reference to an implementation guide that defines the special rules along with other profiles etc. |
Cardinality | 0...1 |
Type | uri |
Modifier | True |
Summary | True |
Comments | Asserting this rule set restricts the content to be only understood by a limited set of trading partners. This inherently limits the usefulness of the data in the long term. However, the existing health eco-system is highly fractured, and not yet ready to define, collect, and exchange data in a generally computable sense. Wherever possible, implementers and/or specification writers should avoid using this element. Often, when used, the URL is a reference to an implementation guide that defines these special rules as part of it's narrative along with other profiles, value sets, etc. |
Invariants |
|
Mappings |
|
Medication.language | |
Definition | The base language in which the resource is written. |
Cardinality | 0...1 |
Type | code |
Binding | A human language. |
Comments | Language is provided to support indexing and accessibility (typically, services such as text to speech use the language tag). The html language tag in the narrative applies to the narrative. The language tag on the resource may be used to specify the language of other presentations generated from the data in the resource. Not all the content has to be in the base language. The Resource.language should not be assumed to apply to the narrative automatically. If a language is specified, it should it also be specified on the div element in the html (see rules in HTML5 for information about the relationship between xml:lang and the html lang attribute). |
Invariants |
|
Mappings |
|
Medication.text | |
Definition | A human-readable narrative that contains a summary of the resource and can be used to represent the content of the resource to a human. The narrative need not encode all the structured data, but is required to contain sufficient detail to make it "clinically safe" for a human to just read the narrative. Resource definitions may define what content should be represented in the narrative to ensure clinical safety. |
Cardinality | 0...1 |
Type | Narrative |
Alias | narrative, html, xhtml, display |
Comments | Contained resources do not have narrative. Resources that are not contained SHOULD have a narrative. In some cases, a resource may only have text with little or no additional discrete data (as long as all minOccurs=1 elements are satisfied). This may be necessary for data from legacy systems where information is captured as a "text blob" or where text is additionally entered raw or narrated and encoded information is added later. |
Invariants |
|
Mappings |
|
Medication.contained | |
Definition | These resources do not have an independent existence apart from the resource that contains them - they cannot be identified independently, and nor can they have their own independent transaction scope. |
Cardinality | 0...* |
Type | Resource |
Alias | inline resources, anonymous resources, contained resources |
Comments | This should never be done when the content can be identified properly, as once identification is lost, it is extremely difficult (and context dependent) to restore it again. Contained resources may have profiles and tags In their meta elements, but SHALL NOT have security labels. |
Mappings |
|
Medication.extension | |
Definition | May be used to represent additional information that is not part of the basic definition of the resource. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. |
Cardinality | 0...* |
Type | Extension |
Alias | extensions, user content |
Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
Slicing | Unordered, Open, by url(Value) |
Invariants |
|
Mappings |
|
Medication.extension:MedicationTradeFamily | |
Definition | A Trade Family or brand associated with a Medication, in particular a Virtual Therapeutic Moiety (VTM). |
Cardinality | 0...1 |
Type | Extension(CodeableConcept) |
Alias | extensions, user content |
Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
Invariants |
|
Mappings |
|
Medication.modifierExtension | |
Definition | May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). |
Cardinality | 0...* |
Type | Extension |
Modifier | True |
Alias | extensions, user content |
Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. |
Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
Slicing | Unordered, Open, by url(Value) |
Invariants |
|
Mappings |
|
Medication.identifier | |
Definition | Business identifier for this medication. |
Cardinality | 0...* |
Type | Identifier |
Summary | True |
Comments | The serial number could be included as an identifier. |
Invariants |
|
Mappings |
|
Medication.code | |
Definition | A code (or set of codes) that specify this medication, or a textual description if no code is available. Usage note: This could be a standard medication code such as a code from RxNorm, SNOMED CT, IDMP etc. It could also be a national or local formulary code, optionally with translations to other code systems. |
Cardinality | 1...1 |
Type | CodeableConcept |
Binding | A coded concept that defines the type of a medication. |
Must Support | True |
Summary | True |
Comments | Depending on the context of use, the code that was actually selected by the user (prescriber, dispenser, etc.) will have the coding.userSelected set to true. As described in the coding datatype: "A coding may be marked as a "userSelected" if a user selected the particular coded value in a user interface (e.g. the user selects an item in a pick-list). If a user selected coding exists, it is the preferred choice for performing translations etc. Other codes can only be literal translations to alternative code systems, or codes at a lower level of granularity (e.g. a generic code for a vendor-specific primary one). |
Invariants |
|
Mappings |
|
Medication.status | |
Definition | A code to indicate if the medication is in active use. |
Cardinality | 0...1 |
Type | code |
Binding | A coded concept defining if the medication is in active use. |
Modifier | True |
Summary | True |
Comments | This status is intended to identify if the medication in a local system is in active use within a drug database or inventory. For example, a pharmacy system may create a new drug file record for a compounded product "ABC Hospital Special Cream" with an active status. At some point in the future, it may be determined that the drug record was created with an error and the status is changed to "entered in error". This status is not intended to specify if a medication is part of a particular formulary. It is possible that the drug record may be referenced by multiple formularies or catalogues and each of those entries would have a separate status. |
Invariants |
|
Mappings |
|
Medication.manufacturer | |
Definition | Describes the details of the manufacturer of the medication product. This is not intended to represent the distributor of a medication product. |
Cardinality | 0...1 |
Type | Reference(Organization) |
Summary | True |
Comments | References SHALL be a reference to an actual FHIR resource, and SHALL be resolveable (allowing for access control, temporary unavailability, etc.). Resolution can be either by retrieval from the URL, or, where applicable by resource type, by treating an absolute reference as a canonical URL and looking it up in a local registry/repository. |
Invariants |
|
Mappings |
|
Medication.form | |
Definition | Describes the form of the item. Powder; tablets; capsule. |
Cardinality | 0...1 |
Type | CodeableConcept |
Binding | A coded concept defining the form of a medication. |
Comments | When Medication is referenced from MedicationRequest, this is the ordered form. When Medication is referenced within MedicationDispense, this is the dispensed form. When Medication is referenced within MedicationAdministration, this is administered form. |
Invariants |
|
Mappings |
|
Medication.amount | |
Definition | Specific amount of the drug in the packaged product. For example, when specifying a product that has the same strength (For example, Insulin glargine 100 unit per mL solution for injection), this attribute provides additional clarification of the package amount (For example, 3 mL, 10mL, etc.). |
Cardinality | 0...1 |
Type | Ratio |
Summary | True |
Comments | The Ratio datatype should only be used to express a relationship of two numbers if the relationship cannot be suitably expressed using a Quantity and a common unit. Where the denominator value is known to be fixed to "1", Quantity should be used instead of Ratio. |
Invariants |
|
Mappings |
|
Medication.ingredient | |
Definition | Identifies a particular constituent of interest in the product. |
Cardinality | 0...* |
Type | BackboneElement |
Comments | The ingredients need not be a complete list. If an ingredient is not specified, this does not indicate whether an ingredient is present or absent. If an ingredient is specified it does not mean that all ingredients are specified. It is possible to specify both inactive and active ingredients. |
Invariants |
|
Mappings |
|
Medication.ingredient.id | |
Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. |
Cardinality | 0...1 |
Type | string |
Mappings |
|
Medication.ingredient.extension | |
Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. |
Cardinality | 0...* |
Type | Extension |
Alias | extensions, user content |
Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
Slicing | Unordered, Open, by url(Value) |
Invariants |
|
Mappings |
|
Medication.ingredient.modifierExtension | |
Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). |
Cardinality | 0...* |
Type | Extension |
Modifier | True |
Summary | True |
Alias | extensions, user content, modifiers |
Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. |
Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
Invariants |
|
Mappings |
|
Medication.ingredient.item[x] | |
Definition | The actual ingredient - either a substance (simple ingredient) or another medication of a medication. |
Cardinality | 1...1 |
Type | CodeableConcept |
Requirements | The ingredient may reference a substance (for example, amoxicillin) or another medication (for example in the case of a compounded product, Glaxal Base). |
Invariants |
|
Mappings |
|
Medication.ingredient.isActive | |
Definition | Indication of whether this ingredient affects the therapeutic action of the drug. |
Cardinality | 0...1 |
Type | boolean |
Requirements | True indicates that the ingredient affects the therapeutic action of the drug (i.e. active). False indicates that the ingredient does not affect the therapeutic action of the drug (i.e. inactive). |
Invariants |
|
Mappings |
|
Medication.ingredient.strength | |
Definition | Specifies how many (or how much) of the items there are in this Medication. For example, 250 mg per tablet. This is expressed as a ratio where the numerator is 250mg and the denominator is 1 tablet. |
Cardinality | 0...1 |
Type | Ratio |
Comments | The Ratio datatype should only be used to express a relationship of two numbers if the relationship cannot be suitably expressed using a Quantity and a common unit. Where the denominator value is known to be fixed to "1", Quantity should be used instead of Ratio. |
Invariants |
|
Mappings |
|
Medication.batch | |
Definition | Information that only applies to packages (not products). |
Cardinality | 0...1 |
Type | BackboneElement |
Invariants |
|
Mappings |
|
Medication.batch.id | |
Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. |
Cardinality | 0...1 |
Type | string |
Mappings |
|
Medication.batch.extension | |
Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. |
Cardinality | 0...* |
Type | Extension |
Alias | extensions, user content |
Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
Slicing | Unordered, Open, by url(Value) |
Invariants |
|
Mappings |
|
Medication.batch.modifierExtension | |
Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). |
Cardinality | 0...* |
Type | Extension |
Modifier | True |
Summary | True |
Alias | extensions, user content, modifiers |
Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. |
Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. |
Invariants |
|
Mappings |
|
Medication.batch.lotNumber | |
Definition | The assigned lot number of a batch of the specified product. |
Cardinality | 0...1 |
Type | string |
Comments | Note that FHIR strings SHALL NOT exceed 1MB in size |
Invariants |
|
Mappings |
|
Medication.batch.expirationDate | |
Definition | When this specific batch of product will expire. |
Cardinality | 0...1 |
Type | dateTime |
Invariants |
|
Mappings |
|
XML View
<StructureDefinition xmlns="http://hl7.org/fhir"> <id value="UKCore-Medication" /> <url value="https://fhir.hl7.org.uk/StructureDefinition/UKCore-Medication" /> <version value="2.3.0" /> <name value="UKCoreMedication" /> <title value="UK Core Medication" /> <status value="active" /> <date value="2023-12-12" /> <publisher value="HL7 UK" /> <contact> <name value="HL7 UK" /> <telecom> <system value="email" /> <value value="ukcore@hl7.org.uk" /> <use value="work" /> <rank value="1" /> </telecom> </contact> <description value="This profile defines the UK constraints and extensions on the International FHIR resource [Medication](https://hl7.org/fhir/R4/Medication.html)." /> <purpose value="This profile is primarily used for the identification and definition of a medication for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use." /> <copyright value="Copyright © 2021+ HL7 UK Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html." /> <fhirVersion value="4.0.1" /> <kind value="resource" /> <abstract value="false" /> <type value="Medication" /> <baseDefinition value="http://hl7.org/fhir/StructureDefinition/Medication" /> <derivation value="constraint" /> <differential> <element id="Medication.extension:MedicationTradeFamily"> <path value="Medication.extension" /> <sliceName value="MedicationTradeFamily" /> <short value="Used to identify a Trade Family or brand associated with a Medication, specifically when the medication is defined using a dm+d Virtual Therapeutic Moiety (VTM) concept" /> <definition value="A Trade Family or brand associated with a Medication, in particular a Virtual Therapeutic Moiety (VTM)." /> <type> <code value="Extension" /> <profile value="https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-MedicationTradeFamily" /> </type> </element> <element id="Medication.code"> <path value="Medication.code" /> <short value="Codes that identify this medication" /> <min value="1" /> <mustSupport value="true" /> <binding> <strength value="preferred" /> <valueSet value="https://fhir.hl7.org.uk/ValueSet/UKCore-MedicationCode" /> </binding> </element> <element id="Medication.form"> <path value="Medication.form" /> <binding> <strength value="preferred" /> <valueSet value="https://fhir.hl7.org.uk/ValueSet/UKCore-MedicationForm" /> </binding> </element> </differential> </StructureDefinition>
JSON View
{ "resourceType": "StructureDefinition", "id": "UKCore-Medication", "url": "https://fhir.hl7.org.uk/StructureDefinition/UKCore-Medication", "version": "2.3.0", "name": "UKCoreMedication", "title": "UK Core Medication", "status": "active", "date": "2023-12-12", "publisher": "HL7 UK", "contact": [ { "name": "HL7 UK", "telecom": [ { "system": "email", "value": "ukcore@hl7.org.uk", "use": "work", "rank": 1 } ] } ], "description": "This profile defines the UK constraints and extensions on the International FHIR resource [Medication](https://hl7.org/fhir/R4/Medication.html).", "purpose": "This profile is primarily used for the identification and definition of a medication for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use.", "copyright": "Copyright © 2021+ HL7 UK Licensed under the Apache License, Version 2.0 (the \"License\"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an \"AS IS\" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html.", "fhirVersion": "4.0.1", "kind": "resource", "abstract": false, "type": "Medication", "baseDefinition": "http://hl7.org/fhir/StructureDefinition/Medication", "derivation": "constraint", "differential": { "element": [ { "id": "Medication.extension:MedicationTradeFamily", "path": "Medication.extension", "sliceName": "MedicationTradeFamily", "short": "Used to identify a Trade Family or brand associated with a Medication, specifically when the medication is defined using a dm+d Virtual Therapeutic Moiety (VTM) concept", "definition": "A Trade Family or brand associated with a Medication, in particular a Virtual Therapeutic Moiety (VTM).", "type": [ { "code": "Extension", "profile": [ "https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-MedicationTradeFamily" ] } ] }, { "id": "Medication.code", "path": "Medication.code", "short": "Codes that identify this medication", "min": 1, "mustSupport": true, "binding": { "strength": "preferred", "valueSet": "https://fhir.hl7.org.uk/ValueSet/UKCore-MedicationCode" } }, { "id": "Medication.form", "path": "Medication.form", "binding": { "strength": "preferred", "valueSet": "https://fhir.hl7.org.uk/ValueSet/UKCore-MedicationForm" } } ] } }
Feedback
Click here to:Report issue for UKCore-Medication, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Examples
COVID Vaccine - An example to illustrate the batch element.
Example UKCore-Medication-COVID-Vaccine
Medication Trade Family - An example to illustrate the Medication Trade Family.
Example UKCore-Extension-MedicationTradeFamily
Timolol - An example to illustrate the form element with a VTM.
Example UKCore-Medication-TimololVTM
Timoptol Eye Drops - An example to illustrate a representation of eye drops.
Example UKCore-Medication-TimoptolEyeDrops
Example Usage Scenarios
The UK Core Medication profile will likely not be used in isolation. It does not provide the context for the medication, e.g. the patient or medication related process. It will be typically used as a referenced resource within
- Profile UKCore-MedicationAdministration
- Profile UKCore-MedicationDispense
- Profile UKCore-MedicationRequest
- Profile UKCore-MedicationStatement
Profile Specific Implementation Guidance:
Mandatory and Must Support Data Elements
The following elements are identified as MustSupport, and it is expected that consumers and suppliers SHALL support these as per the MustSupport Guidance.
Element | Reason |
---|---|
Medication.code | Codes that identify this medication |
Extensions
More information about the extensions on the UKCore-Medication
profile can be found using the links below.
Extension | Context | Link | Comment |
---|---|---|---|
MedicationTradeFamily | Medication.extension | https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-MedicationTradeFamily | Used to identify a Trade Family or brand associated with a Medication, specifically when the medication is defined using a dm+d Virtual Therapeutic Moiety (VTM) concept |
Bindings (differential)
More information about the bindings to UK Core ValueSets can be found below.
Context | Strength | Link |
---|---|---|
Medication.code | preferred | https://fhir.hl7.org.uk/ValueSet/UKCore-MedicationCode |
Medication.form | preferred | https://fhir.hl7.org.uk/ValueSet/UKCore-MedicationForm |
Medication.extension:MedicationTradeFamily | preferred | ValueSet UKCore-MedicationTradeFamily |
code
All medication SHOULD be represented using the NHS dm+d terminology.
- The
Medication.code.coding.system
SHOULD behttps://dmd.nhs.uk
. - The
Medication.code.coding.code
SHOULD be the NHS dm+d concept code. - The
Medication.code.coding.display
SHOULD be the NHS dm+d concept description.
manufacturer
Name of the manufacturer by reference to the organisation.
Where possible, it is expected that the resource being referenced SHOULD conform to Profile UKCore-Organization.
form
Within the dm+d terminology, the Virtual Medicinal Product (VMP), Actual Medicinal Product (AMP), Virtual Medicinal Product Pack (VMPP) and Actual Medicinal Product Pack (AMPP) concepts include a coded form.
This element SHOULD be used where a medication is identified using a dm+d Virtual Therapeutic Moiety (VTM) concept and the prescriber wishes to qualify the VTM with a coded form.
Important
The NHS dm+d holds the coded'<DRUG_FORM>'
attribute for a product within the Virtual Medicinal Product (VMP) concept class. It is held in the ‘VMP Form information’. Some current drug forms are not granular enough allowing for different intended uses. For example ‘capsule’ is attached to both oral capsule VMPs and vaginal capsule VMPs.
The dm+d will revisit a number of drug forms and where appropriate include details of their release characteristics and intended route. These changes will allow dm+d to more closely align with European Directorate for the Quality of Medicines & HealthCare (EDQM) dose forms and the modelling for dose forms in the International SNOMED CT data.
For more information, please see this NHS dm+d update: Updating the NHS dm+d '<DRUG_FORM>' coded attribute within the Virtual Medicinal Product concept class
ingredient
The actual ingredient or content by reference. Where possible, it is expected that the resource being referenced SHOULD conform to one of the following UK Core profiles: